Ascendis Health Limited (JSE:ASC)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc Ascendis Health Statistics
Total Valuation
Ascendis Health has a market cap or net worth of ZAR 513.12 million. The enterprise value is 622.19 million.
| Market Cap | 513.12M |
| Enterprise Value | 622.19M |
Important Dates
The next estimated earnings date is Friday, September 26, 2025.
| Earnings Date | Sep 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ascendis Health has 625.75 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 625.75M |
| Shares Outstanding | 625.75M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.61% |
| Owned by Institutions (%) | 0.09% |
| Float | 44.32M |
Valuation Ratios
The trailing PE ratio is 28.39.
| PE Ratio | 28.39 |
| Forward PE | n/a |
| PS Ratio | 0.70 |
| PB Ratio | 0.78 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 42.04 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.91, with an EV/FCF ratio of -79.14.
| EV / Earnings | 34.41 |
| EV / Sales | 0.85 |
| EV / EBITDA | 24.91 |
| EV / EBIT | n/a |
| EV / FCF | -79.14 |
Financial Position
The company has a current ratio of 0.62, with a Debt / Equity ratio of 0.17.
| Current Ratio | 0.62 |
| Quick Ratio | 0.05 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 4.53 |
| Debt / FCF | -14.41 |
| Interest Coverage | -0.13 |
Financial Efficiency
Return on equity (ROE) is 2.78% and return on invested capital (ROIC) is -0.14%.
| Return on Equity (ROE) | 2.78% |
| Return on Assets (ROA) | -0.11% |
| Return on Invested Capital (ROIC) | -0.14% |
| Return on Capital Employed (ROCE) | -0.26% |
| Revenue Per Employee | 52.46M |
| Profits Per Employee | 1.29M |
| Employee Count | 14 |
| Asset Turnover | 0.76 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Ascendis Health has paid 1.31 million in taxes.
| Income Tax | 1.31M |
| Effective Tax Rate | 6.77% |
Stock Price Statistics
The stock price has increased by +10.00% in the last 52 weeks. The beta is 0.41, so Ascendis Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +10.00% |
| 50-Day Moving Average | 84.22 |
| 200-Day Moving Average | 82.62 |
| Relative Strength Index (RSI) | 29.05 |
| Average Volume (20 Days) | 29,827 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ascendis Health had revenue of ZAR 734.49 million and earned 18.08 million in profits. Earnings per share was 0.03.
| Revenue | 734.49M |
| Gross Profit | 283.26M |
| Operating Income | -1.68M |
| Pretax Income | 19.40M |
| Net Income | 18.08M |
| EBITDA | 11.50M |
| EBIT | -1.68M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 4.18 million in cash and 113.26 million in debt, giving a net cash position of -109.08 million or -0.17 per share.
| Cash & Cash Equivalents | 4.18M |
| Total Debt | 113.26M |
| Net Cash | -109.08M |
| Net Cash Per Share | -0.17 |
| Equity (Book Value) | 658.68M |
| Book Value Per Share | 1.05 |
| Working Capital | -61.98M |
Cash Flow
In the last 12 months, operating cash flow was 12.20 million and capital expenditures -20.07 million, giving a free cash flow of -7.86 million.
| Operating Cash Flow | 12.20M |
| Capital Expenditures | -20.07M |
| Free Cash Flow | -7.86M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 38.57%, with operating and profit margins of -0.23% and 2.46%.
| Gross Margin | 38.57% |
| Operating Margin | -0.23% |
| Pretax Margin | 2.64% |
| Profit Margin | 2.46% |
| EBITDA Margin | 1.57% |
| EBIT Margin | -0.23% |
| FCF Margin | n/a |
Dividends & Yields
Ascendis Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.52% |
| FCF Yield | -1.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ascendis Health has an Altman Z-Score of -6.78 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.78 |
| Piotroski F-Score | 2 |